Advertisement

Topics

Alnylam Acknowledges Rare Disease Day by Highlighting Services to Aid in Rare Disease Diagnosis

08:52 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
– Alnylam Act™ sponsors free third-party genetic counseling and testing services for people at risk for hereditary ATTR amyloidosis (hATTR amyloidosis) – Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading ...

Other Sources for this Article

Alnylam Pharmaceuticals, Inc.
Christine Regan Lindenboom, 617-682-4340
(Investors and Media)
or
Josh Brodsky, 617-551-8276
(Investors)

NEXT ARTICLE

More From BioPortfolio on "Alnylam Acknowledges Rare Disease Day by Highlighting Services to Aid in Rare Disease Diagnosis"

Advertisement
Quick Search
Advertisement
Advertisement